Form EFFECT CNS Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2025 9:30 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Epson Introduces SureColor F370 and New Cotton Primer Solution to Help Creators and Small Businesses Personalize More Products with Dye-Sublimation
- Minieye Technology Unveils Driver Functional Readiness (DFR) Model and AI Cabin Butler at InCabin Europe 2026
- Smartstream unveils new version of Smart Reconciliations Premium – agentic AI reconciliations with GRIT – Governance, ROI, Integration and Trust
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
